Filing Details
- Accession Number:
- 0001179110-16-028878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-22 13:14:35
- Reporting Period:
- 2016-08-19
- Filing Date:
- 2016-08-22
- Accepted Time:
- 2016-08-22 13:14:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441748 | Deborah Woo | 3838 West Parkway Blvd. Salt Lake City UT 84120 | President Of Asia | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-19 | 5,100 | $57.62 | 5,660 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-19 | 4,590 | $133.12 | 1,070 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2016-08-19 | 9,000 | $0.00 | 9,000 | $57.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,000 | 2016-08-15 | 2018-03-15 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights in Table-II
- Weighted average price $133.1172. Price range in multiple transactions was $133 to $133.35 inclusively.
Billionaire Hedge Funds
